Marcel L. Verdonk and David C. Rees. “Group Efficiency: A Guideline for Hits-to-Leads Chemistry.” ChemMedChem 3, no. 8 2008: 1179–1180. DOI: 10.1002/cmdc.200800132.

/in ,

Marcel L. Verdonk and David C. Rees. “Group Efficiency: A Guideline for Hits-to-Leads Chemistry.” ChemMedChem 3, no. 8 2008: 1179–1180. DOI: 10.1002/cmdc.200800132.

Miles Congreve et al. “Recent Developments in Fragment-Based Drug Discovery.” Journal of Medicinal Chemistry 51, no. 13 2008: 3661–3680. DOI: 10.1021/jm8000373.

/in ,

Miles Congreve et al. “Recent Developments in Fragment-Based Drug Discovery.” Journal of Medicinal Chemistry 51, no. 13 2008: 3661–3680. DOI: 10.1021/jm8000373.

Paul G. Wyatt, Andrew J. Woodhead, Valerio Berdini et al. “Identification of N-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.” Journal of Medicinal Chemistry 51, no. 16 2008: 4986–4999. DOI: 10.1021/jm800382h.

/in ,

Paul G. Wyatt, Andrew J. Woodhead, Valerio Berdini et al. “Identification of N-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.” Journal of Medicinal Chemistry 51, no. 16 2008: 4986–4999. DOI: 10.1021/jm800382h.

Verdonk et al. “Protein−Ligand Docking against Non-Native Protein Conformers.” Journal of Chemical Information and Modeling 48, no. 11 2008: 2214–2225. DOI: 10.1021/ci8002254.

/in ,

Verdonk et al. “Protein−Ligand Docking against Non-Native Protein Conformers.” Journal of Chemical Information and Modeling 48, no. 11 2008: 2214–2225. DOI: 10.1021/ci8002254.

Christopher W. Murray et al. “Application of Fragment Screening by X-ray Crystallography to β-Secretase.” Journal of Medicinal Chemistry 50, no. 6 2007: 1116–1123. DOI: 10.1021/jm0611962.

/in ,

Christopher W. Murray et al. “Application of Fragment Screening by X-ray Crystallography to β-Secretase.” Journal of Medicinal Chemistry 50, no. 6 2007: 1116–1123. DOI: 10.1021/jm0611962.

Jhoti, Harren; Leach, Andrew (Eds.). “Structure-based Drug Discovery.” Springer, XII, 252p., Hardcover 2007. ISBN: 978-1-4020-4406-9.

/in ,

Jhoti, Harren; Leach, Andrew (Eds.). “Structure-based Drug Discovery.” Springer, XII, 252p., Hardcover 2007. ISBN: 978-1-4020-4406-9.

Michael J. Hartshorn, et al. “Diverse, High-Quality Test Set for the Validation of Protein−Ligand Docking Performance.” Journal of Medicinal Chemistry 50, no. 4 2007: 726–741. DOI: 10.1021/jm061277y.

/in ,

Michael J. Hartshorn, et al. “Diverse, High-Quality Test Set for the Validation of Protein−Ligand Docking Performance.” Journal of Medicinal Chemistry 50, no. 4 2007: 726–741. DOI: 10.1021/jm061277y.

Miles Congreve et al. “Application of Fragment Screening by X-ray Crystallography to the Discovery of Aminopyridines as Inhibitors of β-Secretase.” Journal of Medicinal Chemistry 50, no. 6 2007: 1124–1132. DOI: 10.1021/jm061197u.

/in ,

Miles Congreve et al. “Application of Fragment Screening by X-ray Crystallography to the Discovery of Aminopyridines as Inhibitors of β-Secretase.” Journal of Medicinal Chemistry 50, no. 6 2007: 1124–1132. DOI: 10.1021/jm061197u.

P. Day, et al. “Structure of a CBS-domain pair from the regulatory γ1 subunit of human AMPK in complex with AMP and ZMP.” Acta Crystallographica D63 2007: 587-596. DOI: 10.1107/S0907444907009110.

/in ,

P. Day, et al. “Structure of a CBS-domain pair from the regulatory γ1 subunit of human AMPK in complex with AMP and ZMP.” Acta Crystallographica D63 2007: 587-596. DOI: 10.1107/S0907444907009110.

Saxty et al. “Identification of Inhibitors of Protein Kinase B Using Fragment-Based Lead Discovery.” Journal of Medicinal Chemistry 50, no. 10 2007: 2293–2296. DOI: 10.1021/jm070091b.

/in ,

Saxty et al. “Identification of Inhibitors of Protein Kinase B Using Fragment-Based Lead Discovery.” Journal of Medicinal Chemistry 50, no. 10 2007: 2293–2296. DOI: 10.1021/jm070091b.